Medical Microbiology The manufacture of medicines: product contamination and preservation

Sterile Product Preparation and Quality Assurance

Topic overview

Start with the big picture

Terminal sterilisation, performed in the final container, is preferred when the product can tolerate it; methods include steam, dry heat, ionising radiation, and ethylene oxide. When a product cannot tolerate terminal treatment, aseptic processing combines sterile components under controlled conditions, including Class A/ISO-5 airflow within a Class B background. Quality assurance extends beyond the sterilisation step: utilities and environments are monitored, equipment and rooms are qualified, and aseptic processes are challenged through media-fill simulations. Sterilising-grade filters require integrity testing, while personnel practices and cleaning help limit contamination. For multi-dose products, preservative effectiveness is assessed by a challenge test. Together, these measures support sterility and ongoing process control.

Learning objectives

What you'll learn

  • Distinguish terminal sterilisation from aseptic processing and identify when each approach is used.
  • Recognise the role of critical utilities and environmental controls in sterile manufacturing.
  • Describe how qualification, media fills, and filter integrity tests support process assurance.
  • Explain how personnel controls and preservation measures help manage contamination risks.
Ready for the complete lesson?

Continue your study

Work through the complete notes and reinforce the topic with the study tools available in the full lesson.

PharmaProLearn

Excel Beyond Limits